Technical Analysis for SRNE - Sorrento Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 1.57 -2.48% -0.04
SRNE closed down 2.48 percent on Wednesday, November 13, 2019, on 77 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SRNE trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Stochastic Reached Overbought Strength -5.99%
Weak + Overbought Other -5.99%
Overbought Stochastic Strength -5.99%
Upper Bollinger Band Touch Strength -4.85%
Pocket Pivot Bullish Swing Setup -6.55%
Upper Bollinger Band Touch Strength -6.55%
20 DMA Support Bullish -0.63%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.27%
Pocket Pivot Bullish Swing Setup -4.27%

Older signals for SRNE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Sorrento Therapeutics, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel and proprietary biotherapeutics for the treatment of cancer, inflammation, metabolic, and infectious diseases in the United States. The company's G-MAB, a human antibody library platform, facilitates the rapid identification and isolation of highly specific antibody therapeutic product candidates that bind to disease targets appropriate for antibody therapy. Its human antibody library technology is used to construct large human antibody libraries. It has license agreement with OPKO Health, Inc. to develop, manufacture, use, market, sell, offer to sell, import, and export certain products related to the development, manufacture, marketing, and sale of drugs for ophthalmological indications. Sorrento Therapeutics, Inc. is based in San Diego, California.
Medicine Biotechnology Biopharmaceutical Health Cancer Biology Immunology Disease Infectious Diseases Treatment Of Cancer Immune System Inflammation Antibody Monoclonal Antibody Antibody Therapy
Is SRNE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.5
52 Week Low 1.39
Average Volume 1,474,321
200-Day Moving Average 2.7105
50-Day Moving Average 1.8767
20-Day Moving Average 1.582
10-Day Moving Average 1.614
Average True Range 0.121
ADX 20.47
+DI 23.1973
-DI 15.892
Chandelier Exit (Long, 3 ATRs ) 1.417
Chandelier Exit (Short, 3 ATRs ) 1.853
Upper Bollinger Band 1.6913
Lower Bollinger Band 1.4727
Percent B (%b) 0.45
BandWidth 13.817952
MACD Line -0.0581
MACD Signal Line -0.0841
MACD Histogram 0.026
Fundamentals Value
Market Cap 108.28 Million
Num Shares 69 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -2.39
Price-to-Sales 10.91
Price-to-Book 1.87
PEG Ratio -0.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.71
Resistance 3 (R3) 1.72 1.68 1.68
Resistance 2 (R2) 1.68 1.65 1.68 1.67
Resistance 1 (R1) 1.63 1.63 1.61 1.62 1.67
Pivot Point 1.59 1.59 1.59 1.59 1.59
Support 1 (S1) 1.54 1.56 1.52 1.53 1.47
Support 2 (S2) 1.50 1.54 1.50 1.47
Support 3 (S3) 1.45 1.50 1.46
Support 4 (S4) 1.44